A brief intervention of less than three minutes delivered by dermatologists during appointments for usual dermatological care is associated with improved sun protection behaviour in patients, according to this recent study.
A workplace sun safety programme which promotes policy adoption and education is a feasible way of improving occupational skin cancer prevention, according to this recent study.
Pembrolizumab monotherapy is standard of care in patients with advanced melanoma, regardless of first- or second-line therapy or PD-L1 status, according to this recent study.
Baseline LDH, ECOG PS, disease burden, and gene signature appear to be key determinants of survival outcomes in patients with BRAF V600–mutated metastatic melanoma treated with BRAF and/or MEK inhibitors, according to this recent study.
A mobile app for patients already using total body photography is an effective tool in increasing skin self-examination rates and skin examination reminders can provide a better overall experience for a subset of patients, according to this recent study.
The American Academy of Dermatology's national free skin cancer education and screening programme conducted by volunteer dermatologists since 1985 has detected thousands of skin cancers that may have gone undetected or experienced a delay in detection, according to this recent review.
A blood test developed to detect autoantibodies made in response to melanoma was able to detect early stage melanoma in 81.5 per cent of cases, according to this recent Australian study.
Age-standardised rates for keratinocyte cancers are relatively stable in South Australia, however regional variations are evident, according to this recent report.
Higher densities of primary care providers may be linked to increased diagnosis of early-stage melanoma, according to this recent study.
Using integrated genomic analysis, this recent study identified that global DNA methylation influences PD-L1 expression in melanoma, and hence melanoma's ability to evade anti-tumor immune responses. These results have implications for combining epigenetic therapy with immunotherapy.